Insider transactions

Alan J Main

CIK 1227372 · EVP, Innov & Chem Sciences · last filed 2025-03-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$522.0K
Companies
2
Total Filings
37
Lifetime Open-Market Net
$0

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

LXRX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LXRX EVP, Innov & Chem Sciences 281,391 $1.85 $522.0K $0 36 2025-03-03
LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted EVP, Pharmaceutical Research — — — $0 1 2007-02-15

Recent Filings · Page 2 of 4

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-04-24 LXRX Mixed +13,080 -$13.4K EDGAR
2020-03-03 LXRX Mixed +24,493 -$35.3K EDGAR
2020-02-10 LXRX Grant (A) — $0 EDGAR
2019-03-01 LXRX Mixed +13,266 -$37.9K EDGAR
2019-02-08 LXRX Grant (A) — $0 EDGAR
2018-03-02 LXRX Mixed +9,571 -$42.3K EDGAR
2018-02-12 LXRX Grant (A) — $0 EDGAR
2017-03-01 LXRX Mixed +9,030 -$88.2K EDGAR
2017-02-13 LXRX Grant (A) — $0 EDGAR
2016-03-02 LXRX Mixed +8,053 -$43.1K EDGAR
Showing 11–20 of 37
Page 2 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.